|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for AMFR |
 Gene summary |
| Basic gene Info. | Gene symbol | AMFR |
| Gene name | autocrine motility factor receptor, E3 ubiquitin protein ligase | |
| Synonyms | GP78|RNF45 | |
| Cytomap | UCSC genome browser: 16q21 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001144.5, NM_138958.1, | |
| Description | E3 ubiquitin-protein ligase AMFRRING finger protein 45 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 603243 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000159461 | ||
| HPRD : 09130 | ||
| Vega : OTTHUMG00000133239 | ||
| Protein | UniProt: Q9UKV5 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_AMFR | |
| BioGPS: 267 | ||
| Pathway | NCI Pathway Interaction Database: AMFR | |
| KEGG: AMFR | ||
| REACTOME: AMFR | ||
| Pathway Commons: AMFR | ||
| Context | iHOP: AMFR | |
| ligand binding site mutation search in PubMed: AMFR | ||
| UCL Cancer Institute: AMFR | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0000209 | protein polyubiquitination | 17310145 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process | 11724934 | GO:0051259 | protein oligomerization | 17310145 |
| Top |
| Ligand binding site mutations for AMFR |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | C364 | R366P | LUAD | 1 | C356 | L354V | OV | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for AMFR |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | C356 | L354V | -1.2380279 | C364 | R366P | -0.58432334 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for AMFR from PDB |
| Top |
| Differential gene expression and gene-gene network for AMFR |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for AMFR |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| umls:C0002395 | Alzheimer Disease | 1 | Biomarker |
| umls:C0242656 | Disease Progression | 1 | Biomarker |
| umls:C0005695 | Urinary Bladder Neoplasms | 1 | Biomarker |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for AMFR |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of AMFR go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 2lxh | C | C356 | ZN | ZINC(2+) | 2lxp | C | C356 | ZN | ZINC(2+) | 4lad | B | C356 | ZN | ZINC(2+) | 2lxh | C | C364 | ZN | ZINC(2+) | 2lxp | C | C364 | ZN | ZINC(2+) | 4lad | B | C364 |
| Top |
| Conservation information for LBS of AMFR |
| Multiple alignments for Q9UKV5 in multiple species |
| LBS | AA sequence | # species | Species | C341 | NNDD-CAICWD | 2 | Homo sapiens, Mus musculus | C341 | NGDDRCVVCWE | 1 | Caenorhabditis elegans | C344 | D-CAICWDSMQ | 2 | Homo sapiens, Mus musculus | C344 | DRCVVCWELLG | 1 | Caenorhabditis elegans | C356 | ARKLPCGHLFH | 2 | Homo sapiens, Mus musculus | C356 | SRRLPCSHQFH | 1 | Caenorhabditis elegans | C364 | LFHNSCLRSWL | 2 | Homo sapiens, Mus musculus | C364 | QFHDWCLMWWL | 1 | Caenorhabditis elegans | C375 | EQDTSCPTCRM | 2 | Homo sapiens, Mus musculus | C375 | AQDSSCPTCRC | 1 | Caenorhabditis elegans | C378 | TSCPTCRMSLN | 2 | Homo sapiens, Mus musculus | C378 | SSCPTCRCTIP | 1 | Caenorhabditis elegans | H358 | KLPCGHLFHNS | 2 | Homo sapiens, Mus musculus | H358 | RLPCSHQFHDW | 1 | Caenorhabditis elegans | H361 | CGHLFHNSCLR | 2 | Homo sapiens, Mus musculus | H361 | CSHQFHDWCLM | 1 | Caenorhabditis elegans |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |